Collectively, these studies reveal that β-1,4-GalT-V can regulate a VEGF-independent pathway to induce angiogenesis via recruiting LacCer and Notch-1 in addition to the trans-differentiation of glioma stem-like cells into endothelial cells [80]. The gene discussed is VEGFA; the disease is central nervous system cancer.